Advisory Services Network’s INmune Bio INMB Stock Holding History

Advisory Services Network’s Portfolio INMB Stock Details INMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-90	Closed	-$581	–	2515
2023 Q1	$581	Hold	90	–	–	﹤0.01%	3720
2022 Q4	$571	Buy	+90	New	+$639	﹤0.01%	3718
2021 Q3	–	Sell	-3,108	Closed	-$55K	–	2314
2021 Q2	$55K	Buy	+3,108	New	+$41.9K	﹤0.01%	1946
2020 Q4	–	Sell	-1,363	Closed	-$14K	–	3489
2020 Q3	$14K	Buy	+1,363	New	+$13.9K	﹤0.01%	2241
2020 Q1	–	Sell	-500	Closed	-$3K	–	3165
2019 Q4	$3K	Buy	+500	New	+$2.41K	﹤0.01%	2758

Other funds holding INMB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

QCG

Quadrant Capital Group Cincinnati, Ohio $3.34B AUM 29.16% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisory Services Network's INMB Position: Q2 2023 in Review

Advisory Services Network sold out of INmune Bio (INMB) in Q2 2023, closing a stake of 90 shares — an estimated $581 sold.

Advisory Services Network first reported a position in INMB in Q4 2019 and held it in 5 quarters. The position peaked at $55K in Q2 2021. 33 funds tracked by Wall St. Rank hold INMB as of Q2 2023.

Advisory Services Network reported no remaining INmune Bio position as of Q2 2023 after selling out during the quarter.
Advisory Services Network sold 90 INmune Bio shares in Q2 2023, an estimated $581.
Advisory Services Network first reported a position in INmune Bio in Q4 2019 and held it in 5 quarters.
Advisory Services Network's INmune Bio position peaked at $55K in Q2 2021.
33 funds tracked by Wall St. Rank held INmune Bio as of Q2 2023.

Based on Advisory Services Network's 13F filing for Q2 2023, filed 9 Aug 2023.